Research map: The tumour microenvironment influences long-term tamoxifen benefit in postmenopausal ER+/HER2− breast cancer patients: a secondary analysis of the randomised Stockholm Tamoxifen (STO-3) trial

Back to the article

Papers in this map

  1. The biology and function of fibroblasts in cancer · Raghu K. Kalluri · 2016 · 4479 citations · Cited by this paper
  2. A Delphi consensus recommendations from China for the management of radiation-induced hearing loss in patients with nasopharyngeal carcinoma · 2026 · Related
  3. Current and future burden of breast cancer: Global statistics for 2020 and 2040 · Melina Arnold · 2022 · 3421 citations · Cited by this paper
  4. Defining the optimal interferon-stimulated genes panel to reflect serum interferon-α levels in patients with systemic lupus erythematosus · 2026 · Related
  5. Palbociclib and Letrozole in Advanced Breast Cancer · Richard S. Finn · 2016 · 3063 citations · Cited by this paper
  6. Optimal doses of cognitive digital therapeutics for pediatric patients with cognitive impairments: A retrospective study based on big data · 2026 · Related
  7. Cancer statistics, 2025 · Rebecca L. Siegel · 2025 · 2992 citations · Cited by this paper
  8. Reduced neural sensitivity to emotional faces and voices in preterm five-year-olds: a comparative study · 2026 · Related
  9. Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer · Gabriel N. Hortobágyi · 2016 · 2067 citations · Cited by this paper
  10. Trimester-specific associations of maternal vitamin D metabolic markers with risks of small vulnerable newborns: a prospective birth cohort study · 2026 · Related
  11. The Swedish cause of death register · Hannah L. Brooke · 2017 · 1410 citations · Cited by this paper
  12. Multimodal analysis reveals asynchronous aging dynamics between endometriosis-associated ovarian cancer and endometriosis patients · 2026 · Related
  13. Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer · Sahar Mahmoud · 2011 · 1401 citations · Cited by this paper
  14. Integrated proteomics and machine learning reveal AHNAK as a discriminative biomarker of atrial fibrillation in heart failure · 2026 · Related
  15. The completeness of the Swedish Cancer Register – a sample survey for year 1998 · Lotti Barlow · 2008 · 1246 citations · Cited by this paper
  16. Comparative validation and local adaptation of gastric cancer risk assessment models in a large multicenter endoscopic screening cohort in China · 2026 · Related
  17. Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System · Clifford A. Hudis · 2007 · 896 citations · Cited by this paper
  18. Circulating metabolomic signatures of ultra-processed and minimally processed food intake and risk of cardiovascular disease and type 2 diabetes: 20-year follow-up in the Whitehall II cohort · 2026 · Related
  19. MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer · Stephen R.D. Johnston · 2019 · 695 citations · Cited by this paper
  20. Functional decline in the final years of life: A multicohort study · 2026 · Related
  21. Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study · H. Raza Ali · 2016 · 683 citations · Cited by this paper
  22. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer · K.G.K. Deepak · 2020 · 631 citations · Cited by this paper
  23. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial · Stephen R.D. Johnston · 2022 · 603 citations · Cited by this paper
  24. Benchmarking of cell type deconvolution pipelines for transcriptomics data · Francisco Avila Cobos · 2020 · 516 citations · Cited by this paper
  25. Clinical Application of the 70-Gene Profile: The MINDACT Trial · Fátima Cardoso · 2008 · 470 citations · Cited by this paper
  26. Stromal cells in the tumor microenvironment: accomplices of tumor progression? · Yan Fei Zhao · 2023 · 441 citations · Cited by this paper
  27. Review of 103 S wedish H ealthcare Q uality R egistries · Louise Emilsson · 2014 · 358 citations · Cited by this paper
  28. Breast cancer heterogeneity and its implication in personalized precision therapy · Liantao Guo · 2023 · 330 citations · Cited by this paper
  29. Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial · P-L Jerevall · 2011 · 228 citations · Cited by this paper
  30. Comprehensive Benchmarking and Integration of Tumor Microenvironment Cell Estimation Methods · Alejandro Jiménez-Sánchez · 2019 · 228 citations · Cited by this paper
  31. CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer · Masanori Oshi · 2020 · 221 citations · Cited by this paper
  32. Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance · Raie Bekele · 2016 · 171 citations · Cited by this paper
  33. Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer · Andreas Heindl · 2017 · 165 citations · Cited by this paper
  34. Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer · Gil Shamai · 2019 · 141 citations · Cited by this paper
  35. Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology · Mariana Segovia Mendoza · 2019 · 137 citations · Cited by this paper
  36. Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer: a randomized phase 3 trial · Fátima Cardoso · 2025 · 137 citations · Cited by this paper
  37. Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes · Marcelo Sobral‐Leite · 2019 · 136 citations · Cited by this paper
  38. Letrozole in the neoadjuvant setting: the P024 trial · Matthew J. Ellis · 2007 · 131 citations · Cited by this paper
  39. Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial · Sherene Loi · 2025 · 118 citations · Cited by this paper

Source: OpenAlex (CC0)